Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
10,694,186
-
Share change
-
+2,240,804
-
Total reported value
-
$8,661,370
-
Price per share
-
$0.81
-
Number of holders
-
26
-
Value change
-
-$5,375,704
-
Number of buys
-
9
-
Number of sells
-
21
Institutional Holders of Vincerx Pharma, Inc. - Common Stock (VINC) as of Q2 2024
As of 30 Jun 2024,
Vincerx Pharma, Inc. - Common Stock (VINC) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,694,186 shares.
The largest 10 holders included
Prosight Management, LP, ARMISTICE CAPITAL, LLC, SAGE RHINO CAPITAL LLC, Rock Springs Capital Management LP, Point72 Asset Management, L.P., GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, ExodusPoint Capital Management, LP, MARSHALL WACE, LLP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.